11,130
Views
186
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Late adverse effects of radiation therapy for rectal cancer – a systematic overview

, , &
Pages 504-516 | Received 10 Dec 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (24)

Lidya Genene Abebe, Abigiya Wondimagegnehu, Aynalem Abraha Woldemariam, Bizu Gelaye, Eva Johanna Kantelhardt & Adamu Addissie. (2021) Validity and Reliability of the Amharic Version of EORTC-QLQ-CR29 Among Colorectal Cancer Patients in Ethiopia. Cancer Management and Research 13, pages 9287-9295.
Read now
Nasrul Wathoni, An Ny Nguyen, Agus Rusdin, Abd Kakhar Umar, Ahmed Fouad Abdelwahab Mohammed, Keiichi Motoyama, I Made Joni & Muchtaridi Muchtaridi. (2020) Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System. Drug Design, Development and Therapy 14, pages 4387-4405.
Read now
Arwen H. Pieterse, Marleen Kunneman, Wilbert B. van den Hout, Monique Baas-Thijssen, Elisabeth D. Geijsen, Heleen M. Ceha, Karin M. Muller, Yvette M. van der Linden, Corrie A. M. Marijnen & Anne M. Stiggelbout. (2019) Patient explicit consideration of tradeoffs in decision making about rectal cancer treatment: benefits for decision process and quality of life. Acta Oncologica 58:7, pages 1069-1076.
Read now
L. Ø. Poulsen, M. K. Yilmaz, K. Ljungmann, N. Jespersen, P. Wille-Jørgensen, L. N. Petersen & U.G. Falkmer. (2018) Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer. Acta Oncologica 57:12, pages 1639-1645.
Read now
Bin Ma, Qingzhou Xu, Yongxi Song, Peng Gao & Zhenning Wang. (2017) Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer. Future Oncology 13:27, pages 2489-2501.
Read now
Yolanda Escobar Alvarez, Claudia Agamez Insignares, Monica Ahumada Olea, Olga Barajas, German Calderillo, Jenny Cecilia Calvache Guamán, Ricardo Caponero, Benjamín A Cavenago Salazar, Auro Del Giglio, Ana Rocío Pupo Araya, Ricardo Villalobos-Valencia, Andrés Yepes Pérez & Nilda Zumelzu Delgado. (2017) Cancer pain management: recommendations from a Latin-American experts panel. Future Oncology 13:27, pages 2455-2472.
Read now
Qun Zhang, Tingjian Zu, Qian Zhou, Jie Wen, Xue Leng & Xunwei Wu. (2017) The Patch Assay Reconstitutes Mature Hair Follicles by Culture-Expanded Human Cells. Regenerative Medicine 12:5, pages 503-511.
Read now
Jiamin Wei, Zhenguo Liu, Kaiming Wu, Dongjie Yang, Yulong He, George Gong Chen, Jian Zhang & Jianhua Lin. (2017) Identification of prognostic and subtype-specific potential miRNAs in thymoma. Epigenomics 9:5, pages 647-657.
Read now
Jonathan Alexander Heiss & Hermann Brenner. (2017) Impact of confounding by leukocyte composition on associations of leukocyte DNA methylation with common risk factors. Epigenomics 9:5, pages 659-668.
Read now
Bengt Glimelius. (2017) On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Upsala Journal of Medical Sciences 122:1, pages 1-10.
Read now
Christian Buchli, Massoud Al Abani, Madelene Ahlberg, Torbjörn Holm, Tone Fokstuen, Matteo Bottai, Jan-Erik Frödin, Ingmar Lax & Anna Martling. (2016) Assessment of testicular dose during preoperative radiotherapy for rectal cancer. Acta Oncologica 55:4, pages 496-501.
Read now
Sara Zalba, Ana Margarita Contreras, María Merino, Iñigo Navarro, Conchita Tros de Ilarduya, Iñaki F Trocóniz, Gerben Koning & María J Garrido. (2016) EGF-Liposomes Promote Efficient EGFR Targeting in Xenograft Colocarcinoma Model. Nanomedicine 11:5, pages 465-477.
Read now
Pavan Sunkireddy, Rupinder Kaur Kanwar, Jagat Ram & Jagat Rakesh Kanwar. (2016) Ultra-Small Algal Chitosan Ocular Nanoparticles With Iron-Binding Milk Protein Prevents the Toxic Effects of Carbendazim Pesticide. Nanomedicine 11:5, pages 495-511.
Read now
Bengt Glimelius & Nina Cavalli-Björkman. (2016) Does shared decision making exist in oncologic practice?. Acta Oncologica 55:2, pages 125-128.
Read now
Marleen Kunneman, Ellen G. Engelhardt, F. L. (Laura) ten Hove, Corrie A. M. Marijnen, Johanneke E. A. Portielje, Ellen M. A. Smets, Hanneke J. C. J. M. (Hanneke) de Haes, Anne M. Stiggelbout & Arwen H. Pieterse. (2016) Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making. Acta Oncologica 55:2, pages 134-139.
Read now
Mikaela L Jorgensen, Jane M Young & Michael J Solomon. (2015) Optimal delivery of colorectal cancer follow-up care: improving patient outcomes. Patient Related Outcome Measures 6, pages 127-138.
Read now
Michael Wilhelmsen, Thomas Kring, Lars N. Jorgensen, Mogens Rørbæk Madsen, Per Jess, Orhan Bulut, Knud Thygesen Nielsen, Claus Lindbjerg Andersen & Hans Jørgen Nielsen. (2014) Determinants of recurrence after intended curative resection for colorectal cancer. Scandinavian Journal of Gastroenterology 49:12, pages 1399-1408.
Read now
Silvia Mezi, Daniela Musio, Errico Orsi, Francesca de Felice, Isabella Verdinelli, Federica Morano, Nicola Raffetto & Vincenzo Tombolini. (2013) Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. Acta Oncologica 52:1, pages 187-190.
Read now
Kjersti Bruheim, Kjell Magne Tveit, Eva Skovlund, Lise Balteskard, Erik Carlsen, Sophie D. Fosså & Marianne G. Guren. (2010) Sexual function in females after radiotherapy for rectal cancer. Acta Oncologica 49:6, pages 826-832.
Read now
Eva Angenete, Tom Öresland, Peter Falk, Michael Breimer, Ragnar Hultborn & Marie-Louise Ivarsson. (2009) Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen components. Acta Oncologica 48:8, pages 1144-1151.
Read now
Sten Friberg & Bengt-Inge Rudén. (2009) Peripheral nerves are sensitive to irradiation, Or: on the pitfalls from too short follow-up times. Acta Oncologica 48:6, pages 807-810.
Read now
Bengt Glimelius. (2008) The dream of a philologist. Acta Oncologica 47:6, pages 991-993.
Read now
Lennart Blomqvist & Bengt Glimelius. (2008) The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncologica 47:1, pages 5-8.
Read now

Articles from other publishers (162)

Omar Bougandoura, Yahia AchourAbdelhalim Zaoui. (2024) Electroporation in Cancer Therapy: A Simplified Model Derived from the Hodgkin–Huxley Model. Bioelectricity.
Crossref
Farshad Seyed Nejad, Mostafa Alizade-Harakiyan, Mehdi Haghi, Rokhsareh Ebrahimi, Mohammad Mahdi Zangeneh, Alireza Farajollahi, Roghayeh Fathi, Reza Mohammadi, Samira Samadi Miandoab, Mohammad Heydarnezhad Asl, Parina Asgharian, Baharak Divband & Amin Ahmadi. (2024) Investigating the effectiveness of iron nanoparticles synthesized by green synthesis method in chemoradiotherapy of colon cancer. Heliyon 10:7, pages e28343.
Crossref
Grigory Demyashkin, Elza Karakaeva, Susanna Saakian, Natalia Tarusova, Amina Guseinova, Anita Vays, Konstantin Gotovtsev, Dmitrii Atiakshin, Petr Shegai & Andrey Kaprin. (2024) Comparative Characterisation of Proliferation and Apoptosis of Colonic Epithelium after Electron Irradiation with 2 GY and 25 GY. International Journal of Molecular Sciences 25:2, pages 1196.
Crossref
Jiali Lyu, Zhenzhu Pang & Jihong Sun. (2024) Radiomics prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Radiology Science 3:1.
Crossref
Tomislav Vlaski, Marija Slavic, Reiner Caspari, Bettine Bilsing, Harald Fischer, Hermann Brenner & Ben Schöttker. (2024) From a Clustering of Adverse Symptoms after Colorectal Cancer Therapy to Chronic Fatigue and Low Ability to Work: A Cohort Study Analysis with 3 Months of Follow-Up. Cancers 16:1, pages 202.
Crossref
Hitesh Malhotra & Rupesh K. Gautam. 2024. Biobased Nanomaterials. Biobased Nanomaterials 337 362 .
D. M. Mens, J. M. van Rees, S. M. Wilting & C. Verhoef. (2023) Can we use a simple blood test to reduce unnecessary adverse effects from radiotherapy by timely identification of radiotherapy-resistant rectal cancers? MeD-Seq rectal study protocol. BMC Cancer 23:1.
Crossref
Paweł Siwiński, Łukasz Dziki, Michał Mik & Adam Dziki. (2023) Risk factors and clinical characteristics of rectal cancer recurrence after radical surgical treatment. Polish Journal of Surgery 96:1, pages 27-33.
Crossref
POONAM JOSHI, NIDHI NAINWAL, SRISHTI MORRIS & VIKAS JAKHMOLA. (2023) A REVIEW ON RECENT ADVANCES ON STIMULI BASED SMART NANOMATERIALS FOR DRUG DELIVERY AND BIOMEDICAL APPLICATION. International Journal of Applied Pharmaceutics, pages 48-59.
Crossref
Väliaho Vesa, Mäkitalo Jaana, Kohonen Ia, Carpelan Anu, Minn Heikki, Ristamäki Raija, Ålgars Annika & Heervä Eetu. (2023) Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer. Clinical and Translational Radiation Oncology 42, pages 100656.
Crossref
Jia Li, Ji Ling Jiang, Yi Mei Chen & Wei Qi Lu. (2023) KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K / AKT signaling pathway . The Journal of Pathology: Clinical Research 9:5, pages 423-435.
Crossref
Mohamed A. Abdelatty, Nema Aboelmagd, Mohamed Fouad Osman, Mohamed Tamer Mohamed & Shady Mohamed. (2023) Multimodality imaging in assessment of intestinal complications pre-stomal reversal. Egyptian Journal of Radiology and Nuclear Medicine 54:1.
Crossref
Max D. Tanaka, Barbara M. Geubels, Brechtje A. Grotenhuis, Corrie A. M. Marijnen, Femke P. Peters, Stevie van der Mierden, Monique Maas & Alice M. Couwenberg. (2023) Validated Pretreatment Prediction Models for Response to Neoadjuvant Therapy in Patients with Rectal Cancer: A Systematic Review and Critical Appraisal. Cancers 15:15, pages 3945.
Crossref
Anna Slipsager, Sofie N. Henrichsen, Ursula G. Falkmer, Karen Dybkær, Mattias Belting & Laurids Ø. Poulsen. (2023) Predictive biomarkers in radioresistant rectal cancer: A systematic review. Critical Reviews in Oncology/Hematology 186, pages 103991.
Crossref
Brijendra Kumar Kashyap, Virendra Vikram Singh, Manoj Kumar Solanki, Anil Kumar, Janne Ruokolainen & Kavindra Kumar Kesari. (2023) Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities. ACS Omega 8:16, pages 14290-14320.
Crossref
Israa Imam, Klara Hammarström & Bengt Glimelius. (2023) Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study. Cancers 15:4, pages 1154.
Crossref
Alastair J. Morton, Adil Rashid, Joanna S. C. Shim, Joe West, David J. Humes & Matthew J. Grainge. (2022) Long‐term adverse effects and healthcare burden of rectal cancer radiotherapy: systematic review and meta‐analysis . ANZ Journal of Surgery 93:1-2, pages 42-53.
Crossref
Takehito Yamamoto, Kenji Kawada, Ryo Matsusue, Shigeru Kato, Yoshiro Itatani, Koya Hida, Takafumi Machimoto, Takashi Yamaguchi & Kazutaka Obama. (2022) Identification of patient subgroups with low risk of postoperative local recurrence for whom total mesorectal excision surgery alone is sufficient: a multicenter retrospective analysis. International Journal of Colorectal Disease 37:10, pages 2207-2218.
Crossref
Esmée A. Dijkstra, Geke A.P. Hospers, Elma Meershoek-Klein Kranenbarg, Joke Fleer, Annet G.H. Roodvoets, Renu R. Bahadoer, Marianne G. Guren, Jolien J.J. Tjalma, Hein Putter, Rogier M.P.H. Crolla, Mathijs P. Hendriks, Jaume Capdevila, Calin Radu, Cornelis J.H. van de Velde, Per J. Nilsson, Bengt Glimelius, Boudewijn van Etten & Corrie A.M. Marijnen. (2022) Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – The RAPIDO trial. Radiotherapy and Oncology 171, pages 69-76.
Crossref
Yi Hsuan Chen, Dominique Molenaar, Carin A. Uyl-de Groot, Marco van Vulpen & Hedwig M. Blommestein. (2022) Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review. Cancers 14:10, pages 2444.
Crossref
Ragini Singh, Ayush Sharma, Joel Saji, Akhela Umapathi, Santosh Kumar & Hemant Kumar Daima. (2022) Smart nanomaterials for cancer diagnosis and treatment. Nano Convergence 9:1.
Crossref
Weikai Chen, Chenxi Zhang, Dagui Chen, Yinghua Li, Shunli Wu, Can Xu, Li Su & Qin Zhang. (2022) Tumor redox microenvironment modulating composite hydrogels for enhanced sonodynamic therapy of colorectal cancer. Journal of Materials Chemistry B 10:12, pages 1960-1968.
Crossref
Deborah S. Keller & Jenny Alex Ky-Miyasaka. 2022. The ASCRS Textbook of Colon and Rectal Surgery. The ASCRS Textbook of Colon and Rectal Surgery 1055 1066 .
Juliana Ominelli, Marcus Valadão, Rodrigo Otavio de Castro Araujo, Andréia Cristina de Melo & Luiz H. Araujo. (2021) The Evolving Field of Neoadjuvant Therapy in Locally-advanced Rectal Cancer: Evidence and Prospects. Clinical Colorectal Cancer 20:4, pages 288-298.
Crossref
Johan Erlandsson, Stina Fuentes, Calin Radu, Jan-Erik Frödin, Hemming Johansson, Yvonne Brandberg, Torbjörn Holm, Bengt Glimelius & Anna Martling. (2021) Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial. BJS Open 5:6.
Crossref
Md. Shahadat Hossain, Mahafujul Islam Quadery Tonmoy, Md. Nur Islam, Md. Sajedul Islam, Ibrahim Khalil Afif, Arpita Singha Roy, Atqiya Fariha, Hasan Al Reza, Newaz Mohammed Bahadur & Md. Mizanur Rahaman. (2021) MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers. Heliyon 7:6, pages e07347.
Crossref
F. Slevin, C. Hanna, A. Appelt & R. Muirhead. (2021) Launch of the National Rectal Cancer Intensity-Modulated Radiotherapy Guidance. Clinical Oncology 33:4, pages 209-213.
Crossref
Stephan Gretschel, Patrick Naumann & Georg Martin Haag. (2021) Einfluss und Toxizität perioperativer Therapien auf die onkologische ChirurgieInfluence and toxicity of perioperative therapy on surgical management of cancer. Der Onkologe 27:4, pages 308-320.
Crossref
Rebekka Kosmala, Emmanouil Fokas, Michael Flentje, Rolf Sauer, Torsten Liersch, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Dirk Arnold, Ralf-Dieter Hofheinz, Michael Ghadimi, Philipp Ströbel, Ludger Staib, Gerhard G. Grabenbauer, Gunnar Folprecht, Simon Kirste, Wolfgang Uter, Christine Gall, Claus Rödel & Bülent Polat. (2021) Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial. European Journal of Cancer 144, pages 281-290.
Crossref
Nkune W. Nkune, Cherie A. Kruger & Heidi Abrahamse. (2021) Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol. Anti-Cancer Agents in Medicinal Chemistry 21:2, pages 137-148.
Crossref
Renu R Bahadoer, Esmée A Dijkstra, Boudewijn van Etten, Corrie A M Marijnen, Hein Putter, Elma Meershoek-Klein Kranenbarg, Annet G H Roodvoets, Iris D Nagtegaal, Regina G H Beets-Tan, Lennart K Blomqvist, Tone Fokstuen, Albert J ten Tije, Jaume Capdevila, Mathijs P Hendriks, Ibrahim Edhemovic, Andrés Cervantes, Per J Nilsson, Bengt Glimelius, Cornelis J H van de Velde, Geke A P Hospers, L. Østergaard, F. Svendsen Jensen, P. Pfeiffer, K.E.J. Jensen, M.P. Hendriks, W.H. Schreurs, H.P. Knol, J.J. van der Vliet, J.B. Tuynman, A.M.E. Bruynzeel, E.D. Kerver, S. Festen, M.E. van Leerdam, G.L. Beets, L.G.H. Dewit, C.J.A. Punt, P.J. Tanis, E.D. Geijsen, P. Nieboer, W.A. Bleeker, A.J. Ten Tije, R.M.P.H. Crolla, A.C.M. van de Luijtgaarden, J.W.T. Dekker, J.M. Immink, F.J.F. Jeurissen, A.W.K.S. Marinelli, H.M. Ceha, T.C. Stam, P. Quarles an Ufford, W.H. Steup, A.L.T. Imholz, R.J.I. Bosker, J.H.M. Bekker, G.J. Creemers, G.A.P. Nieuwenhuijzen, H. van den Berg, W.M. van der Deure, R.F. Schmitz, J.M. van Rooijen, A.F.T. Olieman, A.C.M. van den Bergh, D.J.A. de Groot, K. Havenga, J.C. Beukema, J. de Boer, P.H.J.M. Veldman, E.J.M. Siemerink, J.W.P. Vanstiphout, B. de Valk, Q.A.J. Eijsbouts, M.B. Polée, C. Hoff, A. Slot, H.W. Kapiteijn, K.C.M.J. Peeters, F.P. Peters, P.A. Nijenhuis, S.A. Radema, H. de Wilt, P. Braam, G.J. Veldhuis, D. Hess, T. Rozema, O. Reerink, D. Ten Bokkel Huinink, A. Pronk, J. Vos, M. Tascilar, G.A. Patijn, C. Kersten, O. Mjåland, M. Grønlie Guren, A.N. Nesbakken, J. Benedik, I. Edhemovic, V. Velenik, J. Capdevila, E. Espin, R. Salazar, S. Biondo, V. Pachón, J. die Trill, J. Aparicio, E. Garcia Granero, M.J. Safont, J.C. Bernal, A. Cervantes, A. Espí Macías, L. Malmberg, G. Svaninger, H. Hörberg, G. Dafnis, A. Berglund, L. Österlund, K. Kovacs, J. Hol, S. Ottosson, G. Carlsson, C. Bratthäll, J. Assarsson, B.L. Lödén, P. Hede, I. Verbiené, O. Hallböök, A. Johnsson, M.L. Lydrup, K. Villmann, P. Matthiessen, J.H. Svensson, J. Haux, S. Skullman, T. Fokstuen, T. Holm, P. Flygare, M. Walldén, B. Lindh, O. Lundberg, C. Radu, L. Påhlman, A. Piwowar, K. Smedh, U. Palenius, S. Jangmalm, P. Parinkh, H. Kim & M.L. Silviera. (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. The Lancet Oncology 22:1, pages 29-42.
Crossref
Bengt Glimelius. 2021. Multidisciplinary Treatment of Colorectal Cancer. Multidisciplinary Treatment of Colorectal Cancer 163 178 .
Afsaneh Barzi, April Choi, Denice Tsao-Wei, Syma Iqbal, Anthony El-Khoueiry, Dana Raluca Agafitei, Kyle G Cologne & Heinz-Josef Lenz. (2020) Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer. The Oncologist 25:12, pages e1879-e1885.
Crossref
Ramez Kouzy, Joseph Abi Jaoude, Daniel Lin, Molly B. El Alam, Bruce D. Minsky, Eugene J. Koay, Prajnan Das, Emma B. Holliday, Ann H. Klopp, Lauren E. Colbert & Cullen M. Taniguchi. (2020) Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. JCO Oncology Practice 16:12, pages e1524-e1531.
Crossref
Benjamin Singh, Sandra C. Hayes, Rosalind R. Spence, Megan L. Steele, Guillaume Y. Millet & Laurent Gergele. (2020) Exercise and colorectal cancer: a systematic review and meta-analysis of exercise safety, feasibility and effectiveness. International Journal of Behavioral Nutrition and Physical Activity 17:1.
Crossref
Ahmed N.A.M. Afifi, Maciej Powerski, Dörthe Jechorek, Thomas B. Brunner, Jochen Weigt & Marino Venerito. (2020) Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options. Best Practice & Research Clinical Gastroenterology 48-49, pages 101711.
Crossref
Aakanksha Singh, Rahul Insa, Nadeem Tanveer & Pankaj Kumar Garg. (2020) Radiation-Induced Vasculopathy Precipitating Penile Gangrene. Indian Journal of Surgical Oncology 11:3, pages 459-461.
Crossref
Agne Sipaviciute, Ernestas Sileika, Arvydas Burneckis & Audrius Dulskas. (2020) Late gastrointestinal toxicity after radiotherapy for rectal cancer: a systematic review. International Journal of Colorectal Disease 35:6, pages 977-983.
Crossref
Ian P. Hayes, Elasma Milanzi, Peter Gibbs & Jeanette C. Reece. (2019) Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum. Annals of Surgical Oncology 27:5, pages 1570-1579.
Crossref
E. Shinto, J. Omata, A. Sikina, A. Sekizawa, Y. Kajiwara, K. Hayashi, Y. Hashiguchi, K. Hase & H. Ueno. (2020) Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer. BJS Open 4:2, pages 301-309.
Crossref
B.A. Levick, A.J. Gilbert, K.L. Spencer, A. Downing, J.C. Taylor, P.J. Finan, D.J. Sebag-Montefiore & E.J.A. Morris. (2020) Time to Surgery Following Short-Course Radiotherapy in Rectal Cancer and its Impact on Postoperative Outcomes. A Population-Based Study Across the English National Health Service, 2009–2014. Clinical Oncology 32:2, pages e46-e52.
Crossref
P.J. Brown, R. Hyland, A.J. Quyn, N.P. West, D. Sebag-Montefiore, D. Jayne, P. Sagar & D.J. Tolan. (2019) Current concepts in imaging for local staging of advanced rectal cancer. Clinical Radiology 74:8, pages 623-636.
Crossref
Takehito Yamamoto, Kenji Kawada, Koya Hida, Riki Ganeko, Susumu Inamoto, Mami Yoshitomi, Takeshi Watanabe & Yoshiharu Sakai. (2019) Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns. International Journal of Clinical Oncology 24:6, pages 677-685.
Crossref
Weipeng Sun, Ruoxu Dou, Jiaohua Chen, Sicong Lai, Chi Zhang, Lei Ruan, Liang Kang, Yanhong Deng, Ping Lan, Lei Wang & Jianping Wang. (2018) Impact of Long-Course Neoadjuvant Radiation on Postoperative Low Anterior Resection Syndrome and Quality of Life in Rectal Cancer: Post Hoc Analysis of a Randomized Controlled Trial. Annals of Surgical Oncology 26:3, pages 746-755.
Crossref
F. Fekih-Romdhane, D. Yazid, S.B. Ahmed, R. Labbane & M. Cheour. (2019) Évaluation de la fonction sexuelle chez les hommes ayant un cancer colorectal traité. Sexologies 28:1, pages 31-42.
Crossref
Ryan M. Lanning & Karyn A. Goodman. 2019. Comprehensive Rectal Cancer Care. Comprehensive Rectal Cancer Care 365 403 .
Andrew P. Zbar. 2019. Comprehensive Rectal Cancer Care. Comprehensive Rectal Cancer Care 355 364 .
Bengt Glimelius. 2019. Comprehensive Rectal Cancer Care. Comprehensive Rectal Cancer Care 335 353 .
Kimihiro Yamashita, Takeru Matsuda, Hiroshi Hasegawa, Junko Mukohyama, Akira Arimoto, Tomoko Tanaka, Masashi Yamamoto, Yoshiko Matsuda, Shingo Kanaji, Tetsu Nakamura, Yasuo Sumi, Satoshi Suzuki & Yoshihiro Kakeji. (2018) Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectives. Annals of Gastroenterological Surgery 3:1, pages 24-33.
Crossref
Vincent Ho, Liping Chung, Amandeep Singh, Vivienne Lea, Askar Abubakar, Stephanie H. Lim, Weng Ng, Mark Lee, Paul de Souza, Joo-Shik Shin & Cheok Soon Lee. (2018) Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis. BMC Cancer 18:1.
Crossref
Ti-Hao Wang, Chia-Jen Liu, Tze-Fan Chao, Tzeng-Ji Chen & Yu-Wen Hu. (2018) Second primary malignancy risk after radiotherapy in rectal cancer survivors. World Journal of Gastroenterology 24:40, pages 4586-4595.
Crossref
Jesse Fischer, Tim Eglinton, Frank Frizelle & Mark Hampton. (2018) Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity?. Antioxidants 7:10, pages 136.
Crossref
Rodrigo Andaur, Julio C. Tapia, José Moreno, Leopoldo Soto, Ricardo Armisen & Katherine Marcelain. (2018) Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells. Oncotarget 9:41, pages 26387-26405.
Crossref
M. Dattani, C. Marijnen, B. Moran, D. Tait, C. Cunningham, M. Rodriguez‐Bigas & G. Brown. (2018) Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?. Colorectal Disease 20:S1, pages 92-96.
Crossref
. (2018) 9 - Tossicità Da Trattamento Radioterapico E Da Terapia Sistemica Per Neoplasia Vescicale. Tumori Journal 104:2_suppl, pages S35-S39.
Crossref
Consuelo Rosa, Monica Di Tommaso, Luciana Caravatta, Annamaria Vinciguerra, Antonietta Augurio, Francesca Perrotti, Albina Allajbej, Marco Regoli, Isaia AL Zecca, Marta Di Nicola & Domenico Genovesi. (2018) Assessment of bowel and anal sphincter function after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Tumori Journal 104:2, pages 121-127.
Crossref
D. Brandenbarg, J. H. W. M. Korsten, M. Y. Berger & A. J. Berendsen. (2017) The effect of physical activity on fatigue among survivors of colorectal cancer: a systematic review and meta-analysis. Supportive Care in Cancer 26:2, pages 393-403.
Crossref
Mark Lawler, Deborah Alsina, Richard A Adams, Annie S Anderson, Gina Brown, Nicola S Fearnhead, Stephen W Fenwick, Stephen P Halloran, Daniel Hochhauser, Mark A Hull, Viktor H Koelzer, Angus G K McNair, Kevin J Monahan, Inke Näthke, Christine Norton, Marco R Novelli, Robert J C Steele, Anne L Thomas, Lisa M Wilde, Richard H Wilson & Ian Tomlinson. (2018) Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut 67:1, pages 179-193.
Crossref
Erhan Akgun, Serdar Ozkok, Mevlut Tekin, Tayfun Yoldas, Cemil Caliskan, Timur Kose, Bulent Karabulut, Murat Sezak, Nevra Elmas & Omer Ozutemiz. (2017) The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. World Journal of Surgical Oncology 15:1.
Crossref
E. Lockhart, K. Bak, L.J. Schreiner, D.C. Hodgson, E. Gutierrez, P. Warde & M.B. Sharpe. (2017) Best Practice Recommendations for the Retention of Radiotherapy Records. Clinical Oncology 29:11, pages e195-e202.
Crossref
D. Azria, J. Doyen, M. Jarlier, I. Martel-Lafay, C. Hennequin, P. Etienne, V. Vendrely, E. François, G. de La Roche, O. Bouché, X. Mirabel, B. Denis, L. Mineur, J. Berdah, M. Mahé, Y. Bécouarn, O. Dupuis, G. Lledo, J. Seitz, L. Bedenne, S. Gourgou-Bourgade, B. Juzyna, T. Conroy & J. Gérard. (2017) Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer. Annals of Oncology 28:10, pages 2436-2442.
Crossref
F. Goupy, E. Chajon, J. Castelli, É. Le Prisé, L. Duvergé, N. Jaksic, G. Vogin, É. Monpetit, V. Klein, L. de Bosschère & P. Maingon. (2017) Contraintes de doses aux organes à risque en radiothérapie conformationnelle et stéréotaxique : intestin grêle et duodénum. Cancer/Radiothérapie 21:6-7, pages 613-618.
Crossref
Bin Ma, Peng Gao, Hongchi Wang, Qingzhou Xu, Yongxi Song, Xuanzhang Huang, Jingxu Sun, Junhua Zhao, Junlong Luo, Yu Sun & Zhenning Wang. (2017) What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long‐term outcomes over the past decades? A systematic review and meta‐analysis based on 41,121 patients. International Journal of Cancer 141:5, pages 1052-1065.
Crossref
Jin Cheon Kim, Jong Lyul Lee, Abdulrahman Muaod Alotaibi, Yong Sik Yoon, Chan Wook Kim & In Ja Park. (2017) Robot-assisted intersphincteric resection facilitates an efficient sphincter-saving in patients with low rectal cancer. International Journal of Colorectal Disease 32:8, pages 1137-1145.
Crossref
Simon Gollins, Brendan Moran, Richard Adams, Chris Cunningham, Simon Bach, Arthur Sun Myint, Andrew Renehan, Sharad Karandikar, Vicky Goh, Davide Prezzi, Gerald Langman, Sam Ahmedzai & Ian Geh. (2017) Association of Coloproctology of Great Britain & Ireland ( ACPGBI ): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Multidisciplinary Management . Colorectal Disease 19:S1, pages 37-66.
Crossref
Nickola Pallin & Jane Richardson. (2017) Dietary advice provided to those undergoing pelvic radiotherapy. Journal of Radiotherapy in Practice 16:2, pages 119-132.
Crossref
P. M. Vogt, T. R. Mett, C. Henkenberens, C. Radtke & R. Ipaktchi. (2017) Plastische Rekonstruktion von StrahlenfolgenPlastic reconstruction of radiation injuries. Der Chirurg 88:6, pages 541-552.
Crossref
Chang Ge, Mengxia Wu, Guifang Chen, Guanying Yu, Dehui Ji & Shaozhao Wang. (2017) Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data. Oncology Letters 13:4, pages 2777-2783.
Crossref
Thomas D. Mullen, Edward Y. Kim & Smith Apisarnthanarax. (2017) Short-Course Radiation Therapy Versus Long-Course Chemoradiation in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer: New Insights from Randomized Trials. Current Colorectal Cancer Reports 13:2, pages 165-174.
Crossref
A.J.M. Rombouts, N. Hugen, M.A.G. Elferink, T. Feuth, P.M.P. Poortmans, I.D. Nagtegaal & J.H.W. de Wilt. (2017) Incidence of second tumors after treatment with or without radiation for rectal cancer. Annals of Oncology 28:3, pages 535-540.
Crossref
Noralie H. Geessink, Yvonne Schoon, Hanneke C.P. van Herk, Harry van Goor & Marcel G.M. Olde Rikkert. (2017) Key elements of optimal treatment decision-making for surgeons and older patients with colorectal or pancreatic cancer: A qualitative study. Patient Education and Counseling 100:3, pages 473-479.
Crossref
A Martling, K E Smedby, H Birgisson, H Olsson, F Granath, A Ekbom & B Glimelius. (2017) Risk of second primary cancer in patients treated with radiotherapy for rectal cancer. British Journal of Surgery 104:3, pages 278-287.
Crossref
Te Vuong, Slobodan Devic & Krzysztof Bujko. 2018. Alternate Fractionation in Radiotherapy. Alternate Fractionation in Radiotherapy 229 239 .
Oriol Pares, Ines Santiago, Carlo Greco & Richard Heald. (2016) Total Mesorectal Irradiation: The “Next Step” in the Multidisciplinary Management of Rectal Adenocarcinoma?. Diseases of the Colon & Rectum 59:12, pages 1222-1226.
Crossref
Bengt Glimelius, Tor Åge Myklebust, Kristina Lundqvist, Arne Wibe & Marianne G. Guren. (2016) Two countries – Two treatment strategies for rectal cancer. Radiotherapy and Oncology 121:3, pages 357-363.
Crossref
A.H. Elliot, A. Martling, B. Glimelius, H. Johansson & P.J. Nilsson. (2016) Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer. European Journal of Surgical Oncology (EJSO) 42:11, pages 1667-1673.
Crossref
P. M. Vogt, T. R. Mett, C. Henkenberens, C. Radtke & R. Ipaktchi. (2016) Plastische Rekonstruktion von StrahlenfolgenPlastic reconstruction of radiation injuries. Der Onkologe 22:9, pages 699-710.
Crossref
Rianne de Jong, Lotte Lutkenhaus, Niek van Wieringen, Jorrit Visser, Jan Wiersma, Koen Crama, Debby Geijsen & Arjan Bel. (2016) Plan selection strategy for rectum cancer patients: An interobserver study to assess clinical feasibility. Radiotherapy and Oncology 120:2, pages 207-211.
Crossref
E.J.A. Morris, P.J. Finan, K. Spencer, I. Geh, A. Crellin, P. Quirke, J.D. Thomas, S. Lawton, R. Adams & D. Sebag-Montefiore. (2016) Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clinical Oncology 28:8, pages 522-531.
Crossref
Y. Kulu, T. Hackert, J. Debus, M.-A. Weber, M. W. Büchler & A. Ulrich. (2016) Rolle der neoadjuvanten Strahlentherapie beim RektumkarzinomRole of neoadjuvant radiotherapy for rectal cancer. Der Chirurg 87:7, pages 573-578.
Crossref
Hang ZhengMiao WangJing WuZhi-Ming WangHai-Jun NanHe Sun. (2016) Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation. Biochemistry and Cell Biology 94:3, pages 213-220.
Crossref
Lotte J. Lutkenhaus, Rianne de Jong, Elisabeth D. Geijsen, Jorrit Visser, Niek van Wieringen & Arjan Bel. (2016) Potential dosimetric benefit of an adaptive plan selection strategy for short-course radiotherapy in rectal cancer patients. Radiotherapy and Oncology 119:3, pages 525-530.
Crossref
F. Luca, M. Valvo, M. Guerra-Cogorno, D. Simo, E. Blesa-Sierra, R. Biffi & C. Garberoglio. (2016) Functional results of robotic total intersphincteric resection with hand-sewn coloanal anastomosis. European Journal of Surgical Oncology (EJSO) 42:6, pages 841-847.
Crossref
M. Güthle & T. Seufferlein. (2016) Medikamentöse Behandlung gastrointestinaler TumorenPharmacological treatment of gastrointestinal cancer. Der Gastroenterologe 11:3, pages 160-169.
Crossref
H. Jervoise N. Andreyev. (2016) GI Consequences of Cancer Treatment: A Clinical Perspective. Radiation Research 185:4, pages 341-348.
Crossref
Per Loftas, Gunnar Arbman, Xiao-Feng Sun, David Edler, Erik Syk & Olof Hallbook. (2016) FXYD-3 expression in relation to local recurrence of rectal cancer. Radiation Oncology Journal 34:1, pages 52-58.
Crossref
S. Gollins & D. Sebag-Montefiore. (2016) Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer. Clinical Oncology 28:2, pages 146-151.
Crossref
Emmanouil P. Pappou & Martin R. Weiser. 2016. The ASCRS Textbook of Colon and Rectal Surgery. The ASCRS Textbook of Colon and Rectal Surgery 517 533 .
Zerrin Ozgen, Sevgi Ozden, Beste M Atasoy, Hazan Ozyurt, Rasim Gencosmanoglu & Nese Imeryuz. (2015) Long-term effects of neoadjuvant chemoradiotherapy followed by sphincter-preserving resection on anal sphincter function in relation to quality of life among locally advanced rectal cancer patients: a cross-sectional analysis. Radiation Oncology 10:1.
Crossref
Marleen Kunneman, Corrie A.M. Marijnen, Monique C.M. Baas-Thijssen, Yvette M. van der Linden, Tom Rozema, Karin Muller, Elisabeth D. Geijsen, Anne M. Stiggelbout & Arwen H. Pieterse. (2015) Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making. Radiotherapy and Oncology 117:2, pages 338-342.
Crossref
Zhe-Qi Chu, Jie Yuan, Stephen Z. Pinter, Oliver D. Kripfgans, Xue-Ding Wang, Paul L. Carson & Xiao-Jun Liu. (2015) Temperature imaging with speed of ultrasonic transmission tomography for medical treatment control: A physical model-based method. Chinese Physics B 24:10, pages 104303.
Crossref
Francesco Sclafani, Clare Peckitt, David Cunningham, Diana Tait, Jordi Giralt, Bengt Glimelius, Susana Roselló Keränen, Andrew Bateman, Tamas Hickish, Josep Tabernero, Janet Thomas, Gina Brown, Jacqueline Oates & Ian Chau. (2015) Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial. International Journal of Radiation Oncology*Biology*Physics 93:2, pages 303-312.
Crossref
K. Kodeda, R. Johansson, N. Zar, H. Birgisson, M. Dahlberg, S. Skullman, G. Lindmark, B. Glimelius, L. Påhlman & A. Martling. (2015) Time trends, improvements and national auditing of rectal cancer management over an 18‐year period. Colorectal Disease 17:9.
Crossref
Marleen Kunneman, Anne M. Stiggelbout, Corrie A.M. Marijnen & Arwen H. Pieterse. (2015) Probabilities of benefit and harms of preoperative radiotherapy for rectal cancer: What do radiation oncologists tell and what do patients understand?. Patient Education and Counseling 98:9, pages 1092-1098.
Crossref
Alexandra Gilbert, Lucy Ziegler, Maisie Martland, Susan Davidson, Fabio Efficace, David Sebag-Montefiore & Galina Velikova. (2015) Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. International Journal of Radiation Oncology*Biology*Physics 92:3, pages 555-567.
Crossref
P. Bondeven, S. Laurberg, R. H. Hagemann‐Madsen & B. Ginnerup Pedersen. (2015) Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence. Colorectal Disease 17:3, pages 216-224.
Crossref
Aleksandra Kawczyk-Krupka, Andrzej M. Bugaj, Wojciech Latos, Katarzyna Wawrzyniec, Piotr Oleś, Anna Mertas, Zenon Czuba, Wojciech Król, Karolina Sieroń-Stołtny & Aleksander Sieroń. (2015) ALA-mediated photodynamic effect on apoptosis induction and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1) by colon cancer cells in normoxia and in hypoxia-like conditions in vitro. Photodiagnosis and Photodynamic Therapy 12:1, pages 27-35.
Crossref
Marleen Kunneman, Arwen H. Pieterse, Anne M. Stiggelbout & Corrie A.M. Marijnen. (2015) Which benefits and harms of preoperative radiotherapy should be addressed? A Delphi consensus study among rectal cancer patients and radiation oncologists. Radiotherapy and Oncology 114:2, pages 212-217.
Crossref
H. J. N. Andreyev. (2015) Pelvic radiation disease. Colorectal Disease 17:1, pages 2-6.
Crossref
Anouk J. M. Rombouts, Cherry E. Koh, Jane M. Young, Lindy Masya, Rachael Roberts, Katie De-loyde, Johannes H. W. de Wilt & Michael J. Solomon. (2015) Does Radiotherapy of the Primary Rectal Cancer Affect Prognosis After Pelvic Exenteration for Recurrent Rectal Cancer?. Diseases of the Colon & Rectum 58:1, pages 65-73.
Crossref
M Kunneman, C A M Marijnen, T Rozema, H M Ceha, D A R H Grootenboers, K J Neelis, A M Stiggelbout & A H Pieterse. (2014) Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed. British Journal of Cancer 112:1, pages 39-43.
Crossref
Bengt Glimelius. 2015. Multidisciplinary Treatment of Colorectal Cancer. Multidisciplinary Treatment of Colorectal Cancer 133 146 .
Anne Benard, Eliane C. M. Zeestraten, Inès J. Goossens-Beumer, Hein Putter, Cornelis J. H. van de Velde, Dave S. B. Hoon & Peter J. K. Kuppen. (2014) DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence. Apoptosis 19:11, pages 1581-1593.
Crossref
Lisette M. Wiltink, Tina Y.T. Chen, Remi A. Nout, Elma Meershoek-Klein Kranenbarg, Marta Fiocco, Søren Laurberg, Cornelis J.H. van de Velde & Corrie A.M. Marijnen. (2014) Health-related quality of life 14years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomised trial. European Journal of Cancer 50:14, pages 2390-2398.
Crossref
Angeliki Kotti, Annica Holmqvist, Maria Albertsson & Xiao-Feng Sun. (2014) SPARCL1 Expression Increases With Preoperative Radiation Therapy and Predicts Better Survival in Rectal Cancer Patients. International Journal of Radiation Oncology*Biology*Physics 88:5, pages 1196-1202.
Crossref
C.J.H. van de Velde, P.G. Boelens, P.J. Tanis, E. Espin, P. Mroczkowski, P. Naredi, L. Pahlman, H. Ortiz, H.J. Rutten, A.J. Breugom, J.J. Smith, A. Wibe, T. Wiggers & V. Valentini. (2014) Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012. European Journal of Surgical Oncology (EJSO) 40:4, pages 454-468.
Crossref
Katrine Jossing Emmertsen, Tina Yen-Ting Chen & Soren Laurberg. (2021) Functional results after treatment for rectal cancer. Journal of Coloproctology 34:01, pages 055-061.
Crossref
Marie-Luise Sautter-Bihl, Werner Hohenberger, Rainer Fietkau, Claus Roedel, Heinz Schmidberger & Rolf Sauer. (2013) MRI-Based Treatment of Rectal Cancer: Is Prognostication of the Recurrence Risk Solid Enough to Render Radiation Redundant?. Annals of Surgical Oncology 21:1, pages 197-204.
Crossref
Ming-Yii Huang, Chin-Fan Chen, Chun-Ming Huang, Hsiang-Lin Tsai, Yung-Sung Yeh, Cheng-Jen Ma, Chan-Han Wu, Chien-Yu Lu, Chee-Yin Chai, Chih-Jen Huang & Jaw-Yuan Wang. (2014) Helical Tomotherapy Combined with Capecitabine in the Preoperative Treatment of Locally Advanced Rectal Cancer. BioMed Research International 2014, pages 1-12.
Crossref
H Jervoise N Andreyev, Barbara E Benton, Amyn Lalji, Christine Norton, Kabir Mohammed, Heather Gage, Kjell Pennert & James O Lindsay. (2013) Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. The Lancet 382:9910, pages 2084-2092.
Crossref
Patrizia Ciammella, Maria Paola Ruggieri, Maria Galeandro, Nunziata D’Abbiero, Alessandro Giunta & Cinzia Iotti. (2013) Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of lifeRadioterapia ipofrazionata short-course neoadiuvante in associazione alla chemioterapia nelle neoplasie rettali operabili in stadio localmente avanzato: controllo locale e qualità di vita. La radiologia medica 118:8, pages 1397-1411.
Crossref
A. Wibe, W. L. Law, V. Fazio & C. P. Delaney. (2013) Tailored rectal cancer treatment – a time for implementing contemporary prognostic factors?. Colorectal Disease 15:11, pages 1333-1342.
Crossref
Ning Li, Weiming Zhu, Jianfeng Gong, Yi Li, Wenkui Yu, Qiyi Chen, Ling Ni, Liang Zhang, Lili Gu & Jieshou Li. (2013) Ileal or ileocecal resection for chronic radiation enteritis with small bowel obstruction: outcome and risk factors. The American Journal of Surgery 206:5, pages 739-747.
Crossref
B. Glimelius, E. Tiret, A. Cervantes & D. Arnold. (2013) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 24, pages vi81-vi88.
Crossref
Gillian Knowles, Rachel Haigh, Catriona McLean, Hamish A. Phillips, Malcolm G. Dunlop & Farhat V.N. Din. (2013) Long term effect of surgery and radiotherapy for colorectal cancer on defecatory function and quality of life. European Journal of Oncology Nursing 17:5, pages 570-577.
Crossref
Sidse Bregendahl, Katrine Jøssing Emmertsen, Jørgen Lous & Søren Laurberg. (2013) Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Disease, pages n/a-n/a.
Crossref
Juliette Sheridan, Miriam Tosetto, Julie Gorman, Diarmuid O’Donoghue, Kieran Sheahan, John Hyland, Hugh Mulcahy, David Gibbons & Jacintha O’Sullivan. (2012) Effects of Radiation on Levels of DNA Damage in Normal Non-adjacent Mucosa from Colorectal Cancer Cases. Journal of Gastrointestinal Cancer 44:1, pages 41-45.
Crossref
Timothy L. Fitzgerald, Tithe Biswas, Kevin O’Brien, Emmanuel E. Zervos & Jan H. Wong. (2012) Neoadjuvant Radiotherapy for Rectal Cancer: Adherence to Evidence‐Based Guidelines in Clinical Practice. World Journal of Surgery 37:3, pages 639-645.
Crossref
Luca Incrocci & Pernille Tine Jensen. (2013) Pelvic Radiotherapy and Sexual Function in Men and Women. The Journal of Sexual Medicine 10:Supplement_1, pages 53-64.
Crossref
Eliane C.M. Zeestraten, Peter J.K. Kuppen, Cornelis J.H. van de Velde & Corrie A.M. Marijnen. (2012) Prediction in Rectal Cancer. Seminars in Radiation Oncology 22:2, pages 175-183.
Crossref
D Pettersson, T Holm, H Iversen, L Blomqvist, B Glimelius & A Martling. (2012) Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. British Journal of Surgery 99:4, pages 577-583.
Crossref
Ziting Wang, Kep Yong Loh, Kok-Yang Tan & Emile Chung-Hou Woo. (2011) The role of lateral lymph node dissection in the management of lower rectal cancer. Langenbeck's Archives of Surgery 397:3, pages 353-361.
Crossref
Michał Romaniszyn, Piotr Richter, Piotr Walega, Jakub Kenig, Marcin Nowak & Wojciech Nowak. (2012) Low-Anterior-Resection Syndrome. How Does Neoadjuvant Radiotherapy and Low Resection of the Rectum Influence the Function of Anal Sphincters in Patients with Rectal Cancer? Preliminary Results of a Functional Assessment Study. Polish Journal of Surgery 84:4.
Crossref
Jasper Nijkamp, Barry Doodeman, Corrie Marijnen, Andrew Vincent & Corine van Vliet-Vroegindeweij. (2012) Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board. Radiotherapy and Oncology 102:1, pages 22-29.
Crossref
Morten Brændengen, Kjell Magne Tveit, Kjersti Bruheim, Milada Cvancarova, Åke Berglund & Bengt Glimelius. (2011) Late Patient-Reported Toxicity After Preoperative Radiotherapy or Chemoradiotherapy in Nonresectable Rectal Cancer: Results From a Randomized Phase III Study. International Journal of Radiation Oncology*Biology*Physics 81:4, pages 1017-1024.
Crossref
J H Lefevre, A Amiot, F Joly, F Bretagnol & Y Panis. (2011) Risk of recurrence after surgery for chronic radiation enteritis. British Journal of Surgery 98:12, pages 1792-1797.
Crossref
Fergal J. Fleming, Lars Påhlman & John R. T. Monson. (2011) Neoadjuvant Therapy in Rectal Cancer. Diseases of the Colon & Rectum 54:7, pages 901-912.
Crossref
Marit Tiefenthal, Per J. Nilsson, Robert Johansson, Bengt Glimelius & Lars Påhlman. (2011) The Effects of Short-Course Preoperative Irradiation on Local Recurrence Rate and Survival in Rectal Cancer: A Population-Based Nationwide Study. Diseases of the Colon & Rectum 54:6, pages 672-680.
Crossref
Jasper Nijkamp, Miranda Kusters, Regina G.H. Beets-Tan, Hendrik Martijn, Geerard L. Beets, Cornelis J.H. van de Velde & Corrie A.M. Marijnen. (2011) Three-Dimensional Analysis of Recurrence Patterns in Rectal Cancer: The Cranial Border in Hypofractionated Preoperative Radiotherapy Can Be Lowered. International Journal of Radiation Oncology*Biology*Physics 80:1, pages 103-110.
Crossref
E. Syk, C. Lenander, P. J. Nilsson, C. A. Rubio & B. Glimelius. (2011) Tumour budding correlates with local recurrence of rectal cancer. Colorectal Disease 13:3, pages 255-262.
Crossref
Antonio Avallone, Paolo Delrio, Biagio Pecori, Fabiana Tatangelo, Antonella Petrillo, Nigel Scott, Pietro Marone, Luigi Aloi, Claudia Sandomenico, Secondo Lastoria, Vincenzo Rosario Iaffaioli, Dario Scala, Giovanni Iodice, Alfredo Budillon & Pasquale Comella. (2011) Oxaliplatin Plus Dual Inhibition of Thymidilate Synthase During Preoperative Pelvic Radiotherapy for Locally Advanced Rectal Carcinoma: Long-Term Outcome. International Journal of Radiation Oncology*Biology*Physics 79:3, pages 670-676.
Crossref
Louise Dulley, Mark Harrison & Rob Glynne-Jones. (2010) One Size Does Not Fit All: Planning Volumes for Radiotherapy in Rectal Cancer—Should We Tailor Radiotherapy Fields to Stage and Risk?. Current Colorectal Cancer Reports 7:1, pages 89-96.
Crossref
Kenneth Mah, Andrea Bezjak, D. Andrew Loblaw, Andrew Gotowiec & Gerald M. Devins. (2010) Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment?. Journal of Cancer Survivorship 5:1, pages 18-26.
Crossref
L.I. Olsson, F. Granström & B. Glimelius. (2011) Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study. European Journal of Cancer 47:3, pages 347-353.
Crossref
P. Hermanek, W. Hohenberger, R. Fietkau & C. Rödel. (2010) Individualized magnetic resonance imaging‐based neoadjuvant chemoradiation for middle and lower rectal carcinoma. Colorectal Disease 13:1, pages 39-47.
Crossref
Pernille T. Jensen. 2011. Cancer and Sexual Health. Cancer and Sexual Health 503 524 .
Kathleen A. Griffith, Deborah B. McGuire & Marguerite Russo. (2010) Meeting Survivors’ Unmet Needs: An Integrated Framework for Survivor and Palliative Care. Seminars in Oncology Nursing 26:4, pages 231-242.
Crossref
F. Jörgren, R. Johansson, L. Damber & G. Lindmark. (2009) Risk factors of rectal cancer local recurrence: population‐based survey and validation of the Swedish rectal cancer registry. Colorectal Disease 12:10, pages 977-986.
Crossref
Dániel Sinkó, Zsolt Baranyai, Csaba Nemeskéri, Dániel Teknős, Valéria Jósa, László Hegedűs & Árpád Mayer. (2010) Symptoms, diagnosis and treatment of radiation-induced enteritis. Orvosi Hetilap 151:36, pages 1450-1454.
Crossref
S. Gollins. (2010) Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer. Colorectal Disease 12, pages 2-24.
Crossref
Kok-Yang Tan, Seiichiro Yamamoto, Shin Fujita, Takayuki Akasu & Yoshihiro Moriya. (2010) Improving prediction of lateral node spread in low rectal cancers—multivariate analysis of clinicopathological factors in 1,046 cases. Langenbeck's Archives of Surgery 395:5, pages 545-549.
Crossref
E. Syk, B. Glimelius & P. J. Nilsson. (2010) Factors Influencing Local Failure in Rectal Cancer: Analysis of 2315 Patients From a Population-Based Series. Diseases of the Colon & Rectum 53:5, pages 744-752.
Crossref
D Pettersson, B Cedermark, T Holm, C Radu, L Påhlman, B Glimelius & A Martling. (2010) Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. British Journal of Surgery 97:4, pages 580-587.
Crossref
Kjersti Bruheim, Marianne G. Guren, Alv A. Dahl, Eva Skovlund, Lise Balteskard, Erik Carlsen, Sophie D. Fosså & Kjell Magne Tveit. (2010) Sexual Function in Males After Radiotherapy for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 76:4, pages 1012-1017.
Crossref
Kjersti Bruheim, Marianne G. Guren, Eva Skovlund, Marianne J. Hjermstad, Olav Dahl, Gunilla Frykholm, Erik Carlsen & Kjell Magne Tveit. (2010) Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 76:4, pages 1005-1011.
Crossref
Prajnan Das, Scott B. Cantor, Crystal L. Parker, Joan B. Zampieri, Andrew Baschnagel, Cathy Eng, Marc E. Delclos, Sunil Krishnan, Nora A. Janjan & Christopher H. Crane. (2009) Long‐term quality of life after radiotherapy for the treatment of anal cancer. Cancer 116:4, pages 822-829.
Crossref
V.S. Theis, R. Sripadam, V. Ramani & S. Lal. (2010) Chronic Radiation Enteritis. Clinical Oncology 22:1, pages 70-83.
Crossref
Kristine A. DonovanLora M. A. ThompsonSarah E. Hoffe. (2010) Sexual Function in Colorectal Cancer Survivors. Cancer Control 17:1, pages 44-51.
Crossref
Rainer Kube, Henry Ptok, David Jacob, Jörg Fahlke, Pawel Mroczkowski, Hans Lippert, Gunther Ziegenhardt, Uwe Schmidt & Ingo Gastinger. (2009) Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity. International Journal of Colorectal Disease 25:1, pages 109-117.
Crossref
Bärbel Jung, Lars Påhlman, Robert Johansson & Erik Nilsson. (2009) Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish rectal cancer registry 1995–2004. BMC Cancer 9:1.
Crossref
Samantha Hendren. (2009) INVITED COMMENTARY. Diseases of the Colon & Rectum 52:12, pages 2014-2015.
Crossref
Tone Fokstuen, Torbjörn Holm & Bengt Glimelius. (2009) Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer. Radiotherapy and Oncology 93:2, pages 293-297.
Crossref
Maria Giulia Zampino, Elena Magni, Maria Cristina Leonardi, Elena Petazzi, Luigi Santoro, Fabrizio Luca, Antonio Chiappa, Giuseppe Petralia, Cristina Trovato, Nicola Fazio, Roberto Orecchia, Franco Nolè & Filippo de Braud. (2009) Capecitabine Initially Concomitant to Radiotherapy Then Perioperatively Administered in Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 75:2, pages 421-427.
Crossref
Péter Metzger & Béla Teleky. (2009) A bél onkológiai sebészeter. Magyar Sebészet 62:4, pages 234-243.
Crossref
Ivan Yau, Té Vuong, Aurélie Garant, Thierry Ducruet, Patrick Doran, Sergio Faria, Sender Liberman, Carole Richard, François Letellier, Patrick Charlebois, Rasmy Loungnarath, Barry Stein & Slobodan Devic. (2009) Risk of Hypogonadism From Scatter Radiation During Pelvic Radiation in Male Patients With Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 74:5, pages 1481-1486.
Crossref
Claus Rödel, Rolf Sauer & Rainer Fietkau. (2009) Die Rolle der Magnetresonanztomographie für die Indikationsstellung zur präoperativen Therapie beim RektumkarzinomThe Role of Magnetic Resonance Imaging to Select Patients for Preoperative Treatment in Rectal Cancer. Strahlentherapie und Onkologie 185:8, pages 488-492.
Crossref
Eva Angenete, Marcus Langenskiöld, Ingrid Palmgren, Peter Falk, Tom Öresland & Marie-Louise Ivarsson. (2009) uPA and PAI-1 in Rectal Cancer—Relationship to Radiotherapy and Clinical Outcome. Journal of Surgical Research 153:1, pages 46-53.
Crossref
Jae Hwan OhDae Yong Kim. (2009) Role of Radiation Therapy as an Adjuvant Treatment in Rectal Cancer Management. Journal of the Korean Society of Coloproctology 25:4, pages 273.
Crossref
C. Rödel & W. Schmiegel. (2008) Rektumkarzinom. best practice onkologie 3:6, pages 4-15.
Crossref
Erik Syk, Michael R. Torkzad, Lennart Blomqvist, Per J. Nilsson & Bengt Glimelius. (2008) Local Recurrence in Rectal Cancer: Anatomic Localization and Effect on Radiation Target. International Journal of Radiation Oncology*Biology*Physics 72:3, pages 658-664.
Crossref
H Birgisson, L Påhlman, U Gunnarsson & B Glimelius. (2008) Authors' reply: Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy ( Br J Surg 2008; 95: 206–213) . British Journal of Surgery 95:6, pages 803-803.
Crossref
A. Doeksen, P. J. Tanis, B. C. Vrouenraets, J. A. H. Gooszen, J. J. B. van Lanschot & W. F. van Tets. (2008) Outcome of Rectal Cancer Surgery After the Introduction of Preoperative Radiotherapy in a Low-Volume Hospital. Journal of Gastrointestinal Cancer 38:2-4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.